|
|
37721
|
Y48
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANAESTHETICS AND THERAPEUTIC GASES
|
|
|
37722
|
Y48.0
|
ADVERSE EFFECTS IN THERAPEUTIC USE, INHALED ANAESTHETICS
|
|
|
37723
|
Y48.1
|
ADVERSE EFFECTS IN THERAPEUTIC USE, PARENTERAL ANAESTHETICS
|
|
|
37724
|
Y48.2
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER AND UNSPECIFIED GENERAL ANAESTHETICS
|
|
|
37725
|
Y48.3
|
ADVERSE EFFECTS IN THERAPEUTIC USE, LOCAL ANAESTHETICS
|
|
|
37726
|
Y48.4
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANAESTHETIC, UNSPECIFIED
|
|
|
37727
|
Y48.5
|
ADVERSE EFFECTS IN THERAPEUTIC USE, THERAPEUTIC GASES
|
|
|
37728
|
Y49
|
ADVERSE EFFECTS IN THERAPEUTIC USE, PSYCHOTROPIC DRUGS, NOT ELSEWHERE CLASSIFIED
|
|
|
37729
|
Y49.0
|
ADVERSE EFFECTS IN THERAPEUTIC USE, TRICYCLIC AND TETRACYCLIC ANTIDEPRESSANTS
|
|
|
37730
|
Y49.1
|
ADVERSE EFFECTS IN THERAPEUTIC USE, MONOAMINE-OXIDASE-INHIBITOR ANTIDEPRESSANTS
|
|
|
37731
|
Y49.2
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER AND UNSPECIFIED ANTIDEPRESSANTS
|
|
|
37732
|
Y49.3
|
ADVERSE EFFECTS IN THERAPEUTIC USE, PHENOTHIAZINE ANTIPSYCHOTICS AND NEUROLEPTIC More ...
|
|
|
37733
|
Y49.4
|
ADVERSE EFFECTS IN THERAPEUTIC USE, BUTYROPHENONE AND THIOXANTHENE NEUROLEPTICS
|
|
|
37734
|
Y49.5
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER ANTIPSYCHOTICS AND NEUROLEPTICS
|
|
|
37735
|
Y49.6
|
ADVERSE EFFECTS IN THERAPEUTIC USE, PSYCHODYSLEPTICS [HALLUCINOGENS]
|
|
|
37736
|
Y49.7
|
ADVERSE EFFECTS IN THERAPEUTIC USE, PSYCHOSTIMULANTS WITH ABUSE POTENTIAL
|
|
|
37737
|
Y49.8
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER PSYCHOTROPIC DRUGS, NOT ELSEWHERE CLAS More ...
|
|
|
37738
|
Y49.9
|
ADVERSE EFFECTS IN THERAPEUTIC USE, PSYCHOTROPIC DRUG, UNSPECIFIED
|
|
|
37739
|
Y50
|
ADVERSE EFFECTS IN THERAPEUTIC USE, CENTRAL NERVOUS SYSTEM STIMULANTS, NOT ELSEW More ...
|
|
|
37740
|
Y50.0
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANALEPTICS
|